
Ukraine's supporter states have agreed on contributions to efforts to end the Russian war at a meeting in Paris, a top EU official said on Tuesday evening.
"We stand ready to commit to a system of politically and legally binding guarantees that will be activated once a ceasefire enters into force," European Council President António Costa posted on X after the consultations.
He stated that the EU will contribute to efforts to ensure the security guarantees that Ukraine needs for any agreement for a lasting peace.
Specifically, Costa mentioned supporting Ukraine on its path to EU membership, which is also intended to secure the country's future prosperity.
He also referred to newly planned financial aid amounting to €90 billion ($105.2 billion) for the next two years, as well as the ongoing EU training mission for the Ukrainian armed forces.
"Ukraine must be in the strongest possible position—before, during, and after any ceasefire," Costa stated.
According to the French government, representatives from more than 30 countries, as well as the EU and NATO, participated in the high-level meeting of the so-called Coalition of the Willing in Paris on Tuesday.
LATEST POSTS
- 1
Deadly attack on kindergarten reported in Sudan - 2
NASA's Apollo 8 moonshot saved 1968. Could Artemis 2 do the same in 2026? - 3
75% of US adults may meet criteria for obesity under new definition, study finds - 4
Members of Kenya-led security mission in Haiti were involved in rapes, U.N. says - 5
Flourishing in a Cutthroat Work Market: Vocation Methodologies
German journalists' union condemns attack on reporters in village
The Best 15 Applications for Efficiency and Association
What's The Friendliest City In The United Kingdom?
What we know about Renee Nicole Good, the woman who was killed by an ICE officer in Minneapolis
Activists guilty over Palestine protest breach
Which sandwich do you find totally delectable? !
Understanding Preschool Projects: Cultivating Abilities and Advancement
Top 5 Top of the line Books of the Year
Thermo Fisher wins contracts as pharma shifts production to US, CEO says













